Docetaxel 20 Mg Injection Suppliers & Bulk Manufacturers
Available Forms: injection
Available Strengths: 20 mg/1 mL, 80 mg/4 mL,160 mg/8 mL
Reference Brands: Docefrez (EU)
Category: Oncology Cancer Care
Docetaxel is an intravenous chemotherapy drug used to treat cancers like breast cancer, NSCLC, prostate cancer, and more. Available in 20 mg/mL, 80 mg/4 mL, and 160 mg/8 mL vials, it is marketed as Taxotere® in both the US and EU, providing key B2B opportunities in oncology.
Product Description:
Docetaxel is an intravenous chemotherapy agent used to treat a variety of cancers, including breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, and head and neck cancers. As a taxane, it works by inhibiting cell division, effectively preventing cancer cell proliferation. Available in 20 mg/mL, 80 mg/4 mL, and 160 mg/8 mL vial strengths, Docetaxel is marketed under the brand name Taxotere® in both the US and EU. The drug offers significant B2B opportunities for pharmaceutical companies targeting oncology treatments in these regions.
Docetaxel 20 Mg Injection — third party manufacturing & bulk supply
Docetaxel 20 Mg Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Docetaxel 20 Mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Docetaxel 20 Mg Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Docetaxel is used as an antineoplastic (anti-cancer) medicine to treat various types of cancers, including breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric cancer, and head and neck cancers. It works by interfering with the normal function of microtubules during cell division, thereby inhibiting the growth and spread of cancer cells.
Docetaxel injection is made from the active pharmaceutical ingredient docetaxel, a semi-synthetic taxane derived from the needles of the European yew tree (Taxus baccata). It is formulated in a solution suitable for intravenous administration, often with solubilizing agents like polysorbate 80.
Common trade names include Taxotere and Docefed.
The original brand Taxotere is manufactured by Sanofi. Generic versions are produced by multiple pharmaceutical companies worldwide.
The generic name is docetaxel.
Brand names include Taxotere and Docefed, along with various regional generics.
Docetaxel injection is manufactured in regulated pharmaceutical facilities in the USA, EU, UK, and other countries depending on the manufacturer and marketing authorization holder.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
